FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US

18,400 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 13600 - 13800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
hl7.fhir.us.davinci-cdexR4ValueSet/cdex-pwk01-attachment-report-type-codeCDex PWK01 Attachment Report Type Code Value Settrial-use2claims2024-05hl7
fhir.cqf.commonR4ValueSet/inactive-conditionCQF Inactive Conditionactive2019-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1095.85Nutrition Diagnosis Groupingactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1095.70Nutrition Education SNOMED CTactive2020-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1095.82Food and Nutrition Related History Groupingactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1248.241Degenerative Neurological Disorderactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1248.239Neuromuscular Disorderactive2023-09hl7
hl7.fhir.us.registry-protocolsR4ValueSet/NewYorkHeartAssociationNew York Heart Association Assessment Scaleactivecic2023-11hl7
hl7.fhir.us.pacio-adiR4ValueSet/ADINoHealthcareAgentIncludedReasonVSNo Healthcare Agent Included Reasontrial-use2pe2025-07hl7
fhir.cdc.opioid-cds-r4R4ValueSet/medicationrequest-category-communityValueSet - Medication Request Category Communityactive2025-07hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-cancer-related-surgical-procedure-vsCancer-Related Surgical Procedure Value Setactive3cic2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7961Medication (Leptospirosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7751Type of Link (TB)active2017-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7860Medication Administered Relative to Treatment (Malaria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8034Medication Duration Unit (Hansen)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8033Frequency Duration Unit (Hansen)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7955Location of Initial Diagnosis (Hansen)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7980Patient Case Status (Hansen)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7651Previous Case Diagnosed By (Rubella)active2017-01
hl7.fhir.us.vdorR4ValueSet/vdor-drug-misuse-vsVDOR Indicated Prescription Drug Misuse or Illicit Drug Useinformativepher2025-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3288Vaccination Contraindication (IIS)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.981Diagnosed Pneumonia By (VZ)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.968Case Classification Statusactive2008-01
hl7.fhir.us.carin-bbR4ValueSet/C4BBInstitutionalClaimSubTypeC4BB Institutional Claim SubType Value Settrial-usefm2025-02hl7
hl7.fhir.us.carin-bbR4ValueSet/C4BBClaimInpatientInstitutionalDiagnosisTypeC4BB Claim Inpatient Institutional Diagnosis Type Value Settrial-usefm2025-02hl7
hl7.fhir.us.carin-bbR4ValueSet/C4BBClaimProcedureTypeC4BB Claim Procedure Type Value Settrial-usefm2025-02hl7
hl7.fhir.us.carin-bbR4ValueSet/C4BBClaimOutpatientInstitutionalDiagnosisTypeC4BB Claim Outpatient Institutional Diagnosis Type Value Settrial-usefm2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3304Parotitis Laterality (Mumps)active2010-01
hl7.fhir.us.carin-bbR4ValueSet/C4BBClaimProfessionalAndNonClinicianDiagnosisTypeC4BB Claim Professional And Non Clinician Diagnosis Type Value Settrial-usefm2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3039Isolate Availability EIP Testingactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7244History of Disease as Evidence Of Immunity (IIS)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7245Serological Evidence Of Immunity (IIS)active2014-01
hl7.fhir.us.carin-bbR4ValueSet/C4BBClaimIdentifierTypeC4BB Claim Identifier Type Value Settrial-usefm2025-02hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTPayerProviderNetworkStatusVSPCT Payer Provider Network Statustrial-usefm2025-06hl7
hl7.fhir.us.davinci-pdexR4ValueSet/PriorAuthServiceTypeCodesPrior Authorization Service Type Codes (X12)informativefm2025-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7982Vaccine Exposure (Brucellosis)active2020-01
hl7.fhir.us.davinci-pctR4ValueSet/PCTPayerBenefitPaymentStatusVSPCT Payer Benefit Payment Statustrial-usefm2025-06hl7
hl7.fhir.us.carin-bbR4ValueSet/C4BBPayerBenefitPaymentStatusC4BB Payer Benefit Payment Status Value Settrial-usefm2025-02hl7
hl7.fhir.us.davinci-pdexR4ValueSet/PDexPayerBenefitPaymentStatusPDex Payer Benefit Payment Statusinformativefm2025-06hl7
signal.core.r4R4ValueSet/questionnaire-dacods-discharge-statusQuestionnaire DACODS Discharge Statusdraft1pahl7
signal.core.r4R4ValueSet/questionnaire-dacods-reason-for-dischargeQuestionnaire Dacods Reason For Dischargedraft2023-09hl7
signal.core.r4R4ValueSet/questionnaire-ccars-reason-for-dischargeQuestionnaire CCARS Reason For Dischargedraft1pahl7
hl7.fhir.us.carin-bbR4ValueSet/C4BBPayerProviderNetworkStatusC4BB Payer Provider Network Status Value Settrial-usefm2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7158State or Province of Exposureactive2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8035Subject of Medication Received (Hansen)active2021-01
hl7.fhir.us.davinci-pctR4ValueSet/PCTAEOBProcessNoteVSPCT AEOB Process Note Typestrial-usefm2025-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7990Specimen Type (Anthrax)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3267Non-Sterile Specimen (Pediatric Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3264Sterile Specimen (Pediatric Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7383Death Reporting Event Reason (NCHS)active2014-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7969Specimen Type (Brucellosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7974Specimen Type (Leptospirosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.964Adverse Event Previously Reportedactive2008-01
signal.core.r4R4ValueSet/location-modeLocationModetrial-use3pa2019-10hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.957Abnormal Chest X-Ray Finding (TB)active2008-01
signal.core.r4R4ValueSet/account-statusAccountStatustrial-use2pa2019-10hl7
hl7.fhir.us.carin-bbR4ValueSet/C4BBPayerClaimPaymentStatusCodeC4BB Payer Claim Payment Status Code Value Settrial-usefm2025-02hl7
signal.core.r4R4ValueSet/location-statusLocationStatustrial-use3pa2019-10hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.980Diagnosed by (VZ)active2017-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.580NYHA Heart Failure Functional Classificationsactive2024-09hl7
hl7.fhir.us.breastcancerR3ValueSet/cimi-context-DeltaFlagVSBC DeltaFlagVS ValueSetdraft2018-08hl7
hl7.fhir.us.directory-queryR4ValueSet/IndividualSpecialtyAndDegreeLicenseCertificateVSIndividual Specialties, Degrees, Licenses, and Certificates Value Setactive2022-12hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/IndividualSpecialtyAndDegreeLicenseCertificateVSIndividual Specialties, Degrees, Licenses, and Certificates VStrial-usefm2025-02hl7
hl7.fhir.us.ndhR4ValueSet/IndividualSpecialtyAndDegreeLicenseCertificateVSIndividual Specialties, Degrees, Licenses, and Certificates Value Settrial-usepa2025-07hl7
hl7.fhir.us.directory-queryR4ValueSet/IndividualAndGroupSpecialtiesVSIndividual and Group Specialtiesactive2022-12hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/IndividualAndGroupSpecialtiesVSIndividual and Group Specialtiestrial-usefm2025-02hl7
hl7.fhir.us.ndhR4ValueSet/IndividualAndGroupSpecialtiesVSIndividual and Group Specialtiestrial-usepa2025-07hl7
fhir.cdc.opioid-cds-r4R4ValueSet/non-opioid-urine-drug-screeningNon-opioid drug urine screeningactive2023-05hl7
fhir.cdc.opioid-cds-r4R4ValueSet/opioid-urine-drug-screeningOpioid drug urine screeningactive2023-05hl7
fhir.cdc.opioid-cds-r4R4ValueSet/xylazine-urine-drug-screening-testsXylazine drug urine screening testsactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1095.2Food and Nutrient Delivery SNOMED CTactive2025-05hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.945Industry (SIC)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8057Infant Anti-HCVTest Result (Hepatitis C Perinatal)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8045Infant HCV Antigen Test Result (Hepatitis C)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8044Infant Nucleic Acid Test Result (Hepatitis C)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3123Birth Outcome (VPD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3122Birth Location (VPD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6070Infections During Pregnancy - Live Birth (NCHS)active2017-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.227Findings Related to Medication Management, Infectious Disease Symptomsactive2021-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3250Vaccines Administered (Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3273Vaccines Administered (Pediatric Flu)active2009-01
signal.core.r4R4ValueSet/questionnaire-ccars-current-living-arrangementQuestionnaire CCARS Current Living Arrangementdraft1pahl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1010.7Clinical Drug Ingredientactive2024-06hl7
hl7.fhir.us.pacio-adiR4ValueSet/ADIInitialTreatmentPMOOptionsVSInitial Treatment Portable Medical Order Optionstrial-use2pe2025-07hl7
fhir.virtually.healthcareR4ValueSet/BARSReferralCodeBARS Referral Codedraft2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3130Injury Type (VPD)active2008-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.308Cardiovascular disease 10Y riskactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1021.41MDP Test HL7 Intensionalactive2019-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.266Rhabdomyolysis Intensionalactive2024-06hl7
hl7.fhir.us.vrdrR4ValueSet/vrdr-intentional-reject-vsIntentional Reject ValueSetactivepher2024-10hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-rhabdomyosarcoma-clinical-group-value-vsRhabdomyosarcoma Clinical Group Valueactivecic2025-02hl7
hl7.fhir.us.breastcancerR3ValueSet/shr-core-PositiveNegativeEquivocalIndeterminateVSBC PositiveNegativeEquivocalIndeterminateVS ValueSetdraft2018-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7615Pre-Pregnancy SerologicalTestInterp (CRS)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7476Positive Negative Equivocal Not Doneactive2016-01
hl7.fhir.us.breastcancerR3ValueSet/oncology-RecurrenceRiskScoreInterpretationVSBC RecurrenceRiskScoreInterpretationVS ValueSetdraft2018-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7822Lab Test Type (Legionellosis)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7336Lab Test Type (Mumps)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7821Lab Test Type (Psittacosis)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7844Lab Test Type (Lyme)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7661Lab Test Type (Measles)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7337Lab Test Type (Pertussis)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3300Lab Test Procedure (Rubella)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7549Test Type (Syphilis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3256Time Frame (Daily Weekly)active2009-01
hl7.fhir.us.registry-protocolsR4ValueSet/InterventionTypesIntervention Typesactivecic2023-11hl7
fhir.org.nz.ig.baseR4ValueSet/nz-residencyNZ Residency statusactive2025-06hl7
hl7.fhir.us.codex-radiation-therapyR4ValueSet/codexrt-radiotherapy-isotope-vsRadiotherapy Isotope Value Setactivecgp2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1221.189Infertility, Maleactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1221.190Infertility, Maleactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1221.191Infertility, Maleactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.1446Covid Toes (Toes and/or Fingers)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.193relatedconditions_COPD I10active2023-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.173Asthma I10active2025-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.102Suicide Attemptactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1248.94Oxygen Partial Pressure in Arterial Bloodactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1248.95Carbon Dioxide Partial Pressure in Arterial Bloodactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1248.96Arterial Blood pHactive2024-01hl7
hl7.fhir.us.ccdaR4ValueSet/1.3.6.1.4.1.12009.10.2.5LOINC Imaging Document Codestrial-usecgp2022-07hl7
hl7.fhir.us.ccdaR4ValueSet/2.16.840.1.113883.11.20.6.1ProcedureNoteDocumentTypeCodestrial-usecgp2018-05hl7
hl7.fhir.us.ccdaR4ValueSet/2.16.840.1.113883.11.20.8.1ProgressNoteDocumentTypeCodetrial-usecgp2018-05hl7
hl7.fhir.us.pacio-adiR4ValueSet/LOINCPOLSTCPRAnswerListLOINC POLST CPR Answer Listtrial-use2pe2025-07hl7
hl7.fhir.us.pacio-adiR4ValueSet/LOINCPOLSTInitialTxAnswerListLOINC POLST Initial Tx Answer Listtrial-use2pe2025-07hl7
hl7.fhir.us.pacio-adiR4ValueSet/LOINCPOLSTMedAssistNutrAnswerListLOINC POLST Med assist nutr Answer Listtrial-use2pe2025-07hl7
hl7.fhir.us.pacio-adiR4ValueSet/LOINCPOLSTDiscussPartAnswerListLOINC POLST discuss part Listtrial-use2pe2025-07hl7
hl7.fhir.us.pacio-adiR4ValueSet/LOINCPOLSTReviewAnswerListLOINC POLST review Answer Listtrial-use2pe2025-07hl7
hl7.fhir.us.registry-protocolsR4ValueSet/RoseDyspneaQRose Dyspnea Questionsactivecic2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.202Serum Creatinineactive2024-02hl7
hl7.fhir.us.registry-protocolsR4ValueSet/SeattleAnginaAsSeattle Angina Answersactivecic2023-11hl7
hl7.fhir.us.davinci-pasR4ValueSet/X12278DiagnosisInformationTypeX12 278 Diagnosis Information Typetrial-use3fm2025-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.635LP(a) Test_ICDactive2025-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7755LTBI Drug Regimen (TB)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7866Lab Test Method (MDRO)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3358Lab Test Name (NND)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7278Lab Test Performed Modifier (CS)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3017Lab Test Result (PHLIP Flu)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6013Lab Test Type (Hepatitis)active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6014Lab Test Type Enzymes (Hepatitis)active2012-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3016Lab Test Order (PHLIP Flu)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.4275Lab Result (Cancer Morphology)active2011-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.50MSI Highactive2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7892Lab Result (Candida auris)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7895Lab Result Carbapenem Resistant Enterobacteriaceactive2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.4024Lab Result (Cysticercosis)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.4067Lab Result (Nontuberculous Mycobacteria)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.4276Lab Result (Pesticide)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7894Lab Test Name (Candida Auris)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7893Lab Test Name Carbapenem Resistant Enterobacteriaactive2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8030Lab Test (Hansen)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7733Lab Test Method (RIBD)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1004Ordered Testactive2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7472Lab Test Type (Arbovirus)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8041Lab Test Type (Leptospirosis)active2021-01
hl7.fhir.us.coreR4ValueSet/us-core-laboratory-test-codesUS Core Laboratory Test Codestrial-use3cgp2022-11hl7
fhir.cdc.opioid-cds-r4R4ValueSet/observation-category-laboratoryObservation Category Laboratoryactive2023-05hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1002Lab Test Result Nameactive2020-01
hl7.fhir.us.breastcancerR3ValueSet/oncology-HER2byFISHVSInterpretationTestsVSBC HER2byFISHVSInterpretationTestsVS ValueSetdraft2018-08hl7
hl7.fhir.us.breastcancerR3ValueSet/oncology-EstrogenReceptorInterpretationTestsVSBC EstrogenReceptorInterpretationTestsVS ValueSetdraft2018-08hl7
hl7.fhir.us.breastcancerR3ValueSet/oncology-HER2byIHCInterpretationTestsVSBC HER2byIHCInterpretationTestsVS ValueSetdraft2018-08hl7
hl7.fhir.us.breastcancerR3ValueSet/oncology-ProgesteroneReceptorInterpretationTestsVSBC ProgesteroneReceptorInterpretationTestsVS ValueSetdraft2018-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1003Observation Methodactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8037Test Type (Brucellosis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3097Present Absent Unknown Not Examinedactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7612Late Clinical Manifestation (STD)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.883PHIN Questionsactive2013-01
signal.core.r4R4ValueSet/questionnaire-ccars-legal-statusQuestionnaire CCARS Legal Statusdraft1pahl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7714Legionella Diagnosis (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7715Legionella Exposure (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7737Legionellosis Serogroup (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7770Length of Time Drug Taken (TB)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7468Length of Gestation in Weeksactive2016-01
hl7.fhir.us.registry-protocolsR4ValueSet/LesionSegmentNumberLesion Segment Numberactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.921Emergency Department Acuityactive2008-01
hl7.fhir.us.mcodeR4ValueSet/mcode-clark-level-value-vsClark Level Value Setactivecic2025-02hl7
signal.core.r4R4ValueSet/questionnaire-answers-statusQuestionnaireResponseStatusdraft3fhir2019-10hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-tnm-distant-metastases-staging-type-max-vsTNM Distant Metastases Staging Type Maximum Value Setactive4cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-tnm-primary-tumor-staging-type-max-vsTNM Primary Tumor Staging Type Maximum Value Setactive4cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-tnm-regional-nodes-staging-type-max-vsTNM Regional Nodes Staging Type Maximum Value Setactive4cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-tnm-stage-group-staging-type-max-vsTNM Stage Group Staging Type Maximum Value Setactive4cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-condition-status-trend-max-vsCondition Status Trend Maximum Value Setactive3cic2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.941Susceptibility Resultactive2008-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.636Lp(a) Test_CPTactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.637LP(a) Testactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.634Lp(a) Test_LOINCactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.633Lp(a) Test_SNOMEDactive2025-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3241Notifiable Event Condition (Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3594Campylobacter Organismactive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.988Countermeasure Encounter Purposeactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.989Countermeasure Encounter Typeactive2008-01
hl7.fhir.us.resp-netR4ValueSet/resp-net-labtest-covid-codesresp-net-labtest-covid-codesdraft2025-07hl7
hl7.fhir.us.resp-netR4ValueSet/resp-net-labtest-flu-codesresp-net-labtest-flu-codesdraft2025-07hl7
hl7.fhir.us.resp-netR4ValueSet/resp-net-labtest-flu-rsv-covid-codesresp-net-labtest-flu-rsv-covid-codesdraft2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6047Message Structure (Syndromic Surveillance)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3244Medication Treatment (Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1073Microbiology Test Result Nameactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1107Notification Section Headeractive2015-01
hl7.fhir.us.resp-netR4ValueSet/resp-net-labtest-rsv-codesresp-net-labtest-rsv-codesdraft2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6048Event Type (Syndromic Surveillance)active2012-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6049Message Type (Syndromic Surveillance)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6050Universal ID Type (Syndromic Surveillance)active2012-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8012Activity Type (Brucellosis)active2021-01